header
November 5, 2018

In This Issue
IN THE SPOTLIGHT
CMS Issues Final Medicare Physician Payment Rule
VOTE!
Signatures being Collected for Citizen Initiated Proposal on Physician Assisted Death
New Web-based Decision Support Tool Helps With Chronic Pain Treatment
Health Insurance Marketplace 2019 Open Enrollment Now Through December 15, 2018
AMA Urges FTC to Act on Insulin Prices
MaineGeneral to Offer X-waiver Course
Ten Takeaways from the Surgeon General's Opioid Report
"Great American Smokeout" November 15th; "Tar Wars" Anti-smoking Education
Webinar: The Changing Landscape of Retirement - Tuesday, November 13 5pm
128th MAINE LEGISLATURE
MMA Presentation on Healthcare Issues Considered by 128th Legislature Now Available
MMA Legislative Committee's Organizational Meeting Scheduled for December 6
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Next Steps in Addressing Maine's Opioid Crisis: 11/7 Presentation Scheduled
Introduction to Lean in Healthcare Full-Day Workshop on Friday, November 9
Division of Disease Surveillance Annual Infectious Disease Conference - November 14
MICIS 3-hour Opioid CME Presentation - November 26 in Portland
Enrollment Underway for Maine’s Physician Executive Leadership Institute - The Advanced Course - Deadline for Enrollment at Discounted Price: November 30th
Identifying Substance Use Early Saves Lives! - SBIRT with Motivational Interviewing Training - 1-day Sessions Offered on Dec 8, Feb 2, Mar 2, Apr 6
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Physician – Leeds
Psychiatric Mental Health NP - Leeds
Psychiatric Nurse Practitioner - Nasson Health Care
Primary Care Physician
PCHC wants to add more Family Physicians at Multiple Locations!
Outpatient Internal Medicine Physician – Bangor, Maine
OB/GYN Physician Opportunity
Franklin Health Behavioral Services is seeking a BC/BE Psychiatrist/Medical Director
Internal Medicine MD or DO (BE/BC)
Podiatrist (Non-Surgical)
Internal Medicine Outpatient Physician
Seeking Medical Director for Family Medical Practice in Waterville, ME
Internal Medicine Physician
Opportunities at the VA for Volunteer Physicians

 
Search Back Issues





 




Follow Us:
Ten Takeaways from the Surgeon General's Opioid Report

In a new report on the opioid epidemic, Surgeon General Jerome Adams, MD, highlights the need for a cultural shift in the nation's perception of substance-abuse disorders (SUDs). He emphasizes that SUDs are chronic-but-treatable diseases.

To remedy the problem, Dr. Adams, an AMA member, suggests that physicians and policymakers focus on evidence-based treatments— both medications and behavioral therapies—that can save lives and restore people's health and wellbeing. The AMA agreed that there is a great need to recognize that patients suffering "require medical intervention, not moral judgment." Here are ten major takeaways from the report:

  1. Only 1 in 4 people, (28.6 percent) with opioid-use disorder (OUD) received specialty treatment for illicit drug use in the past year, 45.5 percent of people with a SUD also have a mental disorder, but only half (51.0 percent) receive treatment for either disorder.
  2. Individuals receiving buprenorphine with counseling have significantly lower total health care costs than individuals receiving little or no treatment for their OUD ($13,578 compared to $31,055). As of September 2018, 44,968 physicians and 8,825 nurse practitioners and physician assistants, are approved to prescribe buprenorphine.
  3. Research has found that, for every dollar spent on prevention programs, the program returns between $0.62 and $64.18 in reduced costs.
  4. Incorporating treatment for multiple SUDs can be beneficial and is associated with a 25 percent increase in the likelihood of maintaining long-term abstinence from alcohol and drug misuse.
  5. Evaluation studies have clearly shown that syringe services programs are effective in reducing HIV and HCV transmission and do not increase rates of community drug use. They help individuals engage in treatment to reduce, manage, and stop their substance use when appropriate.
  6. The introduction of illicitly manufactured fentanyl and other highly potent synthetic opioids to the drug supply makes immediate access to naloxone crucial to effective overdose death prevention. Although regulations vary, most states have passed laws expanding access to naloxone without a patient-specific prescription.
  7. Multiple factors create barriers to widespread use of MAT. These include provider, public, and client attitudes and beliefs about MAT; lack of an appropriate infrastructure for providing medications; payment policies; need for staff training and development; and legislation, policies, and regulations that limit MAT implementation.
  8. An abstinence-only philosophy that avoids the use of medications for opioid treatment is not scientifically supported. Research clearly demonstrates that opioid-agonist therapy leads to better treatment outcomes compared to behavioral treatments alone. Decades of research have shown that the benefits of opioid agonist therapy greatly outweigh the risks associated with diversion.
  9. A public health approach to the opioid crisis will also reduce other harmful consequences, such as infectious disease transmission and neonatal abstinence syndrome.
  10. Effective integration of prevention, treatment, and recovery services across health care systems is key to addressing opioid misuse and its consequences, and it represents the most promising way to improve access to and quality of treatment.

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©